Patent Assignment
Reel/Frame 070623/0472
Assignment of Assignor's Interest
Recorded: 2025-03-25
Pages: 20
Assignor
OSIRIS THERAPEUTICS, INC.
Executed: 2013-10-10
Assignee
MESOBLAST INTERNATIONAL SÀRL
ROUTE DE PRE-BOIS 20, MEYRIN, 1217, SWITZERLAND
Covered Properties
(2)
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application:
17/934,852 →
Publication:
US 2023/0089901
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application:
19/086,003 →
Publication:
US 2025/0312379
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 25, 2025
From: DANILKOVITCH, ALLA; NEWMAN, ROBERT E.; TOM, SAMSON; TON, CHRISTOPHER
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 070623/0526 →
Corrective Assignment to Correct the First Inventor's Name Previously Recorded at Reel: 70623 Frame: 526. Assignor(S) Hereby Confirms the Assignment .
Mar 28, 2025
From: DANILKOVICH, ALLA; NEWMAN, ROBERT E.; TOM, SAMSON; TON, CHRISTOPHER
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 070671/0294 →